FLOXIN

LOE Approaching

ofloxacin

NDAORALTABLET
Approved
Dec 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT06815536N/ARecruiting

Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae

Started Apr 2025
3,291 enrolled
Neisseria Gonorrheae Infection
NCT04678869N/AActive Not Recruiting

CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia)

Started Jun 2022
313 enrolled
Acute Lymphoblastic Leukaemia - Category
NCT03828201Phase 2Recruiting

Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Started Jun 2022
220 enrolled
Tuberculosis, Multidrug-Resistant
NCT04636957Phase 3Unknown

A Phase III Study of Ciprofloxacin Plus Fluocinolone in Acute Otitis Externa (AOE)

Started Nov 2020
600 enrolled
Acute Otitis Externa
NCT04147260Phase 1Completed

Evaluation of Photosafety of BI 730357 Compared to Placebo and the Known Photosensitizing Agent Ciprofloxacin

Started Nov 2019
85 enrolled
Healthy